Dr. Raghad Karim, MD
Claim this profileNEXT Oncology
Studies Solid Tumors
Studies Tumors
3 reported clinical trials
3 drugs studied
Area of expertise
1Solid Tumors
Stage IV
ER positive
KRAS positive
2Tumors
Stage IV
ER positive
KRAS positive
Affiliated Hospitals
Clinical Trials Raghad Karim, MD is currently running
TST001
for Cancer
This is an open label Phase I/IIa, First in Human trial of TST001, a recombinant humanized anti-Claudin 18.2 (CLDN18.2) IgG1 monoclonal antibody as monotherapy or in combination with nivolumab or standard of care. It is being tested against advanced and/or metastatic solid tumors including gastric, gastroesophageal junction, pancreatic cancers.
Recruiting1 award Phase 1 & 21 criteria
Zotatifin
for Solid Tumors
This trial is testing a new drug called Zotatifin for patients with advanced cancers that haven't improved with standard treatments. The drug works by stopping cancer cells from making essential proteins, which may slow or stop the cancer.
Recruiting3 awards Phase 1 & 221 criteria
More about Raghad Karim, MD
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Raghad Karim, MD has experience with
- EFT226
- TST001
- HH2853
Breakdown of trials Raghad Karim, MD has run
Stomach Cancer
Gastroesophageal Junction Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Raghad Karim, MD specialize in?
Raghad Karim, MD focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are ER positive.
Is Raghad Karim, MD currently recruiting for clinical trials?
Yes, Raghad Karim, MD is currently recruiting for 3 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Raghad Karim, MD has studied deeply?
Yes, Raghad Karim, MD has studied treatments such as eFT226, TST001, HH2853.
What is the best way to schedule an appointment with Raghad Karim, MD?
Apply for one of the trials that Raghad Karim, MD is conducting.
What is the office address of Raghad Karim, MD?
The office of Raghad Karim, MD is located at: NEXT Oncology, San Antonio, Texas 78229 United States. This is the address for their practice at the NEXT Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.